TY  - JOUR
AU  - Senere, Michelle
AU  - Rogozinski, Thaddeus
AU  - George, J. Scott
AU  - Mital, Deepak
AU  - Slakey, Douglas
PY  - 2023
DA  - 2023/01/29
TI  - Cytomegalovirus and Kidney Transplantation: An Update
JO  - OBM Transplantation
SP  - 174
VL  - 07
IS  - 01
AB  - Cytomegalovirus (CMV) infection is the most common infection affecting kidney transplant recipients [1]. CMV may be present as asymptomatic viremia or with symptoms ranging from mild to significant tissue-invasive disease [1-3]. Optimal kidney graft function and survival requires that transplant care teams carefully assess individual patient risk of CMV [2, 3]. Appropriate patient surveillance and prophylaxis are essential to ensure the best long-term kidney transplant results. Effective treatment of CMV disease requires a high degree of suspicion and appropriate diagnostic tests. The choice of antiviral medication and duration of treatment are important considerations to ensure optimal patient outcomes and kidney graft function and survival.
SN  - 2577-5820
UR  - https://doi.org/10.21926/obm.transplant.2301174
DO  - 10.21926/obm.transplant.2301174
ID  - Senere2023
ER  -